CLINICAL_TRIALS
trial_result
· 2021-12-13
Clinical Trial Update: Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects [Phase 1]
Summary
Phase 1 trial assessing safety, tolerability, and pharmacokinetics of intravenous KAE609 in healthy subjects for malaria; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2021-12-13